missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18516409

SPARC Antibody (122511) [DyLight 594], Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals FAB941M

Product Code. 18516409

  • € 706.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

SPARC Monoclonal antibody specifically detects SPARC in Human samples. It is validated for ELISA, Immunohistochemistry, Flow Cytometry (Intracellular Staining), CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

SPARC
Monoclonal
DyLight 594
50mM Sodium Borate
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
ELISA, Immunohistochemistry, Flow Cytometry (Intracellular Staining), CyTOF
122511
ELISA, Immunohistochemistry, Intracellular Staining by Flow Cytometry, CyTOF-ready
Basement-membrane protein 40, BM-40, ONcysteine-rich protein, osteonectin, Secreted protein acidic and rich in cysteine, secreted protein, acidic, cysteine-rich (osteonectin)
Mouse myeloma cell line NS0-derived recombinant human SPARC, Ala18-Ile303, Accession # P09486
0.1 mL
Biologically Active Proteins, Cancer, Cell Cycle and Replication
6678
Store at 4°C in the dark.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.